Disposition of 35604 shares by Sharon Mates of Intracellular at 12.73 subject to Rule 16b-3

ITCI Stock  USD 86.03  0.38  0.44%   
Under 52% of Intracellular's investor base is interested to short. The analysis of overall sentiment of trading Intracellular Th stock suggests that many investors are impartial at this time. Intracellular's investing sentiment shows overall attitude of investors towards Intracellular Th.
  
Filed transaction by Intracellular Th Director, Officer: Chairman And Ceo. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Read at macroaxis.com
Disposition of 35604 stock option (right to buy) at 12.73 of Intracellular by Sharon Mates on 29th of August 2024. This event was filed by Intracellular Th with SEC on 2024-08-29. Statement of changes in beneficial ownership - SEC Form 4. Sharon Mates currently serves as co-founder, chairman, ceo and pres of Intracellular Th

Cash Flow Correlation

Intracellular's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Intracellular's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Intracellular Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Intracellular can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Intracellular Fundamental Analysis

We analyze Intracellular's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Intracellular using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Intracellular based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Price To Book

Price To Book Comparative Analysis

Intracellular is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

Intracellular Th Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Intracellular stock to make a market-neutral strategy. Peer analysis of Intracellular could also be used in its relative valuation, which is a method of valuing Intracellular by comparing valuation metrics with similar companies.

Peers

Intracellular Related Equities

CYTHCyclo Therapeutics   6.23   
0%
100.0%
PCRXPacira BioSciences,   5.32   
0%
85.0%
AMRXAmneal Pharmaceuticals,   3.63   
0%
58.0%
IRWDIronwood Pharmaceuticals   2.84   
0%
45.0%
COLLCollegium Pharmaceutical   2.72   
0%
43.0%
AMPHAmphastar   1.53   
0%
24.0%
DVAXDynavax Technologies   1.40   
0%
22.0%
ALKSAlkermes Plc   1.21   
0%
19.0%
ANIPANI Pharmaceuticals   1.12   
0%
17.0%
NBIXNeurocrine Biosciences   0.68   
10.0%
0%
AQSTAquestive Therapeutics   5.50   
88.0%
0%

Complementary Tools for Intracellular Stock analysis

When running Intracellular's price analysis, check to measure Intracellular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intracellular is operating at the current time. Most of Intracellular's value examination focuses on studying past and present price action to predict the probability of Intracellular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intracellular's price. Additionally, you may evaluate how the addition of Intracellular to your portfolios can decrease your overall portfolio volatility.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Bonds Directory
Find actively traded corporate debentures issued by US companies
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing